{"id":"https://openalex.org/W1998413159","doi":"https://doi.org/10.1097/00001813-200602000-00009","title":"Decrease in c-Myc activity enhances cancer cell sensitivity to vinblastine","display_name":"Decrease in c-Myc activity enhances cancer cell sensitivity to vinblastine","publication_year":2006,"publication_date":"2006-01-20","ids":{"openalex":"https://openalex.org/W1998413159","doi":"https://doi.org/10.1097/00001813-200602000-00009","mag":"1998413159","pmid":"https://pubmed.ncbi.nlm.nih.gov/16428936"},"language":"en","primary_location":{"id":"doi:10.1097/00001813-200602000-00009","doi":"https://doi.org/10.1097/00001813-200602000-00009","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00001813-200602000-00009","pdf_url":null,"source":{"id":"https://openalex.org/S158028025","display_name":"Anti-Cancer Drugs","issn_l":"0959-4973","issn":["0959-4973","1473-5741"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Drugs","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038645191","display_name":"C line Bressin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I21491767","display_name":"Aix-Marseille Universit\u00e9","ror":"https://ror.org/035xkbk20","country_code":"FR","type":"education","lineage":["https://openalex.org/I21491767"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"C??line Bressin","raw_affiliation_strings":["CNRS FRE 2737, UFR Pharmacie, University of La Mediterran\u00e9e, Marseille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CNRS FRE 2737, UFR Pharmacie, University of La Mediterran\u00e9e, Marseille, France","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I21491767"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027987072","display_name":"V\u00e9ronique Bourgarel\u2010Rey","orcid":"https://orcid.org/0000-0002-7044-3910","observed_orcids":["https://orcid.org/0000-0002-7044-3910"]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I21491767","display_name":"Aix-Marseille Universit\u00e9","ror":"https://ror.org/035xkbk20","country_code":"FR","type":"education","lineage":["https://openalex.org/I21491767"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"V??ronique Bourgarel-Rey","raw_affiliation_strings":["CNRS FRE 2737, UFR Pharmacie, University of \u2018La Mediterran\u00e9e\u2019, Marseille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CNRS FRE 2737, UFR Pharmacie, University of \u2018La Mediterran\u00e9e\u2019, Marseille, France","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I21491767"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Manon Carr??","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I21491767","display_name":"Aix-Marseille Universit\u00e9","ror":"https://ror.org/035xkbk20","country_code":"FR","type":"education","lineage":["https://openalex.org/I21491767"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Manon Carr??","raw_affiliation_strings":["CNRS FRE 2737, UFR Pharmacie, University of \u2018La Mediterran\u00e9e\u2019, Marseille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CNRS FRE 2737, UFR Pharmacie, University of \u2018La Mediterran\u00e9e\u2019, Marseille, France","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I21491767"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076500661","display_name":"Bertrand Pourroy","orcid":"https://orcid.org/0000-0002-2388-3518","observed_orcids":["https://orcid.org/0000-0002-2388-3518"]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I21491767","display_name":"Aix-Marseille Universit\u00e9","ror":"https://ror.org/035xkbk20","country_code":"FR","type":"education","lineage":["https://openalex.org/I21491767"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Bertrand Pourroy","raw_affiliation_strings":["CNRS FRE 2737, UFR Pharmacie, University of \u2018La Mediterran\u00e9e\u2019, Marseille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CNRS FRE 2737, UFR Pharmacie, University of \u2018La Mediterran\u00e9e\u2019, Marseille, France","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I21491767"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074768819","display_name":"Diego Arango","orcid":"https://orcid.org/0000-0003-2953-3284","observed_orcids":["https://orcid.org/0000-0003-2953-3284"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Diego Arango","raw_affiliation_strings":["Department of Medical Genetics, Biomedicum Helsinki, University of Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Genetics, Biomedicum Helsinki, University of Helsinki, Finland","institution_ids":["https://openalex.org/I133731052"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044960963","display_name":"Diane Braguer","orcid":"https://orcid.org/0000-0003-3950-2318","observed_orcids":["https://orcid.org/0000-0003-3950-2318"]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I21491767","display_name":"Aix-Marseille Universit\u00e9","ror":"https://ror.org/035xkbk20","country_code":"FR","type":"education","lineage":["https://openalex.org/I21491767"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Diane Braguer","raw_affiliation_strings":["CNRS FRE 2737, UFR Pharmacie, University of \u2018La Mediterran\u00e9e\u2019, Marseille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CNRS FRE 2737, UFR Pharmacie, University of \u2018La Mediterran\u00e9e\u2019, Marseille, France","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I21491767"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110191614","display_name":"Y. Barra","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I21491767","display_name":"Aix-Marseille Universit\u00e9","ror":"https://ror.org/035xkbk20","country_code":"FR","type":"education","lineage":["https://openalex.org/I21491767"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Yves Barra","raw_affiliation_strings":["CNRS FRE 2737, UFR Pharmacie, University of \u2018La Mediterran\u00e9e\u2019, Marseille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CNRS FRE 2737, UFR Pharmacie, University of \u2018La Mediterran\u00e9e\u2019, Marseille, France","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I21491767"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5027987072"],"corresponding_institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I21491767"],"apc_list":null,"apc_paid":null,"fwci":1.0105,"has_fulltext":false,"cited_by_count":25,"citation_normalized_percentile":{"value":0.69764064,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"17","issue":"2","first_page":"181","last_page":"187"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.7422000169754028,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.7422000169754028,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.0843999981880188,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.0820000022649765,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/c-myc","display_name":"c-Myc","score":0.9290000200271606},{"id":"https://openalex.org/keywords/vinblastine","display_name":"vinblastine","score":0.9909999966621399},{"id":"https://openalex.org/keywords/drug-sensitivity","display_name":"drug sensitivity","score":0.6819999814033508},{"id":"https://openalex.org/keywords/colon-cancer","display_name":"colon cancer","score":0.6710000038146973},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.9860000014305115},{"id":"https://openalex.org/keywords/mitochondrial-apoptosis","display_name":"mitochondrial apoptosis","score":0.843999981880188},{"id":"https://openalex.org/keywords/mitochondrial-membrane-potential","display_name":"mitochondrial membrane potential","score":0.9179999828338623},{"id":"https://openalex.org/keywords/cytochrome-c-release","display_name":"cytochrome c release","score":0.9959999918937683},{"id":"https://openalex.org/keywords/bcl-2","display_name":"Bcl-2","score":0.9449999928474426},{"id":"https://openalex.org/keywords/p53","display_name":"p53","score":0.9990000128746033},{"id":"https://openalex.org/keywords/vinca-alkaloids","display_name":"vinca alkaloids","score":0.8650000095367432},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.5979999899864197}],"concepts":[{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.758872926235199},{"id":"https://openalex.org/C2777132456","wikidata":"https://www.wikidata.org/wiki/Q282629","display_name":"Vinblastine","level":3,"score":0.6819876432418823},{"id":"https://openalex.org/C2781018059","wikidata":"https://www.wikidata.org/wiki/Q207609","display_name":"Oncogene","level":4,"score":0.6344510912895203},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5789003968238831},{"id":"https://openalex.org/C29311851","wikidata":"https://www.wikidata.org/wiki/Q408223","display_name":"Cytochrome c","level":3,"score":0.551903247833252},{"id":"https://openalex.org/C54009773","wikidata":"https://www.wikidata.org/wiki/Q1429031","display_name":"Transfection","level":3,"score":0.5449418425559998},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5200207233428955},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.46592068672180176},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.4404706656932831},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.4314068555831909},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.42954200506210327},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.4278866946697235},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.41391295194625854},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3399442434310913},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.337105929851532},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1767657995223999},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1165023148059845},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.07115131616592407},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.06848052144050598}],"mesh":[{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003110","descriptor_name":"Colonic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003110","descriptor_name":"Colonic Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004361","descriptor_name":"Drug Tolerance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008564","descriptor_name":"Membrane Potentials","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008928","descriptor_name":"Mitochondria","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011065","descriptor_name":"Poly(ADP-ribose) Polymerases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014747","descriptor_name":"Vinblastine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015536","descriptor_name":"Down-Regulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016193","descriptor_name":"G1 Phase","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016271","descriptor_name":"Proto-Oncogene Proteins c-myc","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D016373","descriptor_name":"DNA, Antisense","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019253","descriptor_name":"Proto-Oncogene Proteins c-bcl-2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D045304","descriptor_name":"Cytochromes c","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051028","descriptor_name":"bcl-2-Associated X Protein","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1097/00001813-200602000-00009","doi":"https://doi.org/10.1097/00001813-200602000-00009","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00001813-200602000-00009","pdf_url":null,"source":{"id":"https://openalex.org/S158028025","display_name":"Anti-Cancer Drugs","issn_l":"0959-4973","issn":["0959-4973","1473-5741"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Drugs","raw_type":"journal-article"},{"id":"pmid:16428936","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16428936","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-cancer drugs","raw_type":"Journal Article"},{"id":"pmh:oai:HAL:hal-00018395v1","doi":null,"is_oa":false,"landing_page_url":"https://hal.science/hal-00018395","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Anti-Cancer Drugs, 2006, 2, pp.181-187","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":40,"referenced_works":["https://openalex.org/W106241224","https://openalex.org/W119228777","https://openalex.org/W410278434","https://openalex.org/W1507207566","https://openalex.org/W1654947539","https://openalex.org/W1825200556","https://openalex.org/W1886460440","https://openalex.org/W1918229896","https://openalex.org/W1984159955","https://openalex.org/W1991707369","https://openalex.org/W1993865998","https://openalex.org/W1999142756","https://openalex.org/W2007057690","https://openalex.org/W2008502680","https://openalex.org/W2037258477","https://openalex.org/W2043061492","https://openalex.org/W2056775926","https://openalex.org/W2058462271","https://openalex.org/W2063221399","https://openalex.org/W2064772366","https://openalex.org/W2074388242","https://openalex.org/W2078859302","https://openalex.org/W2085139762","https://openalex.org/W2085188839","https://openalex.org/W2093349455","https://openalex.org/W2097078602","https://openalex.org/W2103616303","https://openalex.org/W2123575108","https://openalex.org/W2140406739","https://openalex.org/W2145647042","https://openalex.org/W2151125604","https://openalex.org/W2163395716","https://openalex.org/W2164599433","https://openalex.org/W2164778107","https://openalex.org/W2167527436","https://openalex.org/W2320732213","https://openalex.org/W2328799185","https://openalex.org/W2346679923","https://openalex.org/W4250836866","https://openalex.org/W4405993698"],"related_works":["https://openalex.org/W4389021568","https://openalex.org/W2001575726","https://openalex.org/W2033028596","https://openalex.org/W2151125604","https://openalex.org/W2373675619","https://openalex.org/W1994641779","https://openalex.org/W2087730030","https://openalex.org/W2127009916","https://openalex.org/W2107783737","https://openalex.org/W1988388382"],"abstract_inverted_index":{"The":[0],"c-myc":[1,65,164,194],"oncogene":[2,195],"encodes":[3],"for":[4,205],"a":[5,60,76,109,136,140,167,202],"transcriptional":[6],"factor":[7,169],"involved":[8],"in":[9,29,43,67,79,82,95,104,125,147],"many":[10],"cellular":[11,30],"processes":[12],"such":[13],"as":[14],"proliferation,":[15],"differentiation":[16],"and":[17,98,139,170],"apoptosis.":[18],"According":[19],"to":[20,32,47,186],"these":[21],"different":[22,89],"functions,":[23],"the":[24,39,63,121,145,151,160,191,207],"role":[25,40],"of":[26,41,72,93,123,159,179,193,209],"c-Myc":[27,42,148,180],"protein":[28,181],"sensitivity":[31,46,81],"anti-cancer":[33],"drugs":[34],"is":[35,166],"controversial.":[36],"We":[37],"defined":[38],"cancer":[44,53],"cell":[45],"vinblastine":[48],"(VLB)":[49],"using":[50],"human":[51,64],"colon":[52],"cells:":[54],"LoVo":[55],"wild-type":[56],"or":[57],"transfected":[58],"with":[59],"plasmid":[61],"containing":[62],"gene":[66],"antisense":[68,198],"orientation":[69],"(LoVo-mycANS).":[70],"Analysis":[71],"VLB":[73,80,152],"cytotoxicity":[74],"demonstrated":[75,108],"3-fold":[77],"increase":[78],"LoVo-mycANS":[83],"cells.":[84],"Comparison":[85],"between":[86],"cells":[87,94],"revealed":[88],"apoptosis":[90,132,156],"kinetics:":[91],"accumulation":[92],"sub-G1":[96],"phase":[97],"poly(ADP-ribose)":[99],"polymerase":[100],"cleavage":[101],"occurred":[102],"earlier":[103,131,155],"LoVo-mycANS.":[105],"Then,":[106],"we":[107],"mitochondrial":[110],"membrane":[111],"potential":[112],"disruption":[113],"followed":[114],"by":[115,135,196],"cytochrome":[116],"c":[117],"release":[118],"that":[119,174],"indicates":[120],"involvement":[122],"mitochondria":[124],"this":[126,210],"apoptotic":[127],"signaling":[128],"pathway.":[129,162],"This":[130],"was":[133],"accompanied":[134],"Bcl-2":[137],"decrease":[138,146],"p53":[141],"increase.":[142],"In":[143],"conclusion,":[144],"expression":[149],"enhanced":[150],"sensitivity,":[153],"triggering":[154],"through":[157],"induction":[158,165],"intrinsic":[161],"Thus,":[163],"resistance":[168],"our":[171],"findings":[172],"suggest":[173],"tumors":[175],"carrying":[176],"low":[177],"levels":[178],"could":[182],"be":[183],"more":[184],"responsive":[185],"vinca":[187],"alkaloids":[188],"treatment.":[189],"Moreover,":[190],"downregulation":[192],"an":[197],"strategy":[199],"might":[200],"represent":[201],"useful":[203],"goal":[204],"improving":[206],"efficacy":[208],"anti-neoplastic":[211],"drug":[212],"family.":[213]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}